-
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages
ソース: Buzz FX / 25 11 2024 03:31:10 America/Chicago
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat November 25, 2024 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) has received an average r
Read more...